141 related articles for article (PubMed ID: 35871532)
21. p55PIK-PI3K stimulates angiogenesis in colorectal cancer cell by activating NF-κB pathway.
Wang G; Chen C; Yang R; Cao X; Lai S; Luo X; Feng Y; Xia X; Gong J; Hu J
Angiogenesis; 2013 Jul; 16(3):561-73. PubMed ID: 23354733
[TBL] [Abstract][Full Text] [Related]
22. Activation of HIF-1
Schoos A; Gabriel C; Knab VM; Fux DA
J Pharmacol Exp Ther; 2019 Sep; 370(3):480-489. PubMed ID: 31300611
[TBL] [Abstract][Full Text] [Related]
23. PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis.
Fang J; Ding M; Yang L; Liu LZ; Jiang BH
Cell Signal; 2007 Dec; 19(12):2487-97. PubMed ID: 17826033
[TBL] [Abstract][Full Text] [Related]
24. Adiponectin promotes VEGF-A-dependent angiogenesis in human chondrosarcoma through PI3K, Akt, mTOR, and HIF-α pathway.
Lee HP; Lin CY; Shih JS; Fong YC; Wang SW; Li TM; Tang CH
Oncotarget; 2015 Nov; 6(34):36746-61. PubMed ID: 26468982
[TBL] [Abstract][Full Text] [Related]
25. Retinoblastoma binding protein 2 (RBP2) promotes HIF-1α-VEGF-induced angiogenesis of non-small cell lung cancer via the Akt pathway.
Qi L; Zhu F; Li SH; Si LB; Hu LK; Tian H
PLoS One; 2014; 9(8):e106032. PubMed ID: 25162518
[TBL] [Abstract][Full Text] [Related]
26. AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo.
Zhang PC; Liu X; Li MM; Ma YY; Sun HT; Tian XY; Wang Y; Liu M; Fu LS; Wang YF; Chen HY; Liu Z
Biochem Pharmacol; 2020 Feb; 172():113771. PubMed ID: 31863779
[TBL] [Abstract][Full Text] [Related]
27. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis.
Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ
Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688
[TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor, hypoxia-inducible factor 1 alpha and CD34 expressions in early-stage gastric tumors: relationship with pathological factors and prognostic impact on survival.
Cabuk D; Basaran G; Celikel C; Dane F; Yumuk PF; Iyikesici MS; Ekenel M; Turhal NS
Oncology; 2007; 72(1-2):111-7. PubMed ID: 18025805
[TBL] [Abstract][Full Text] [Related]
29. Tanshinone IIA reduces secretion of pro‑angiogenic factors and inhibits angiogenesis in human colorectal cancer.
Zhou L; Sui H; Wang T; Jia R; Zhang Z; Fu J; Feng Y; Liu N; Ji Q; Wang Y; Zhang B; Li Q; Li Y
Oncol Rep; 2020 Apr; 43(4):1159-1168. PubMed ID: 32323837
[TBL] [Abstract][Full Text] [Related]
30. Ellagic acid inhibits VEGF/VEGFR2, PI3K/Akt and MAPK signaling cascades in the hamster cheek pouch carcinogenesis model.
Kowshik J; Giri H; Kishore TK; Kesavan R; Vankudavath RN; Reddy GB; Dixit M; Nagini S
Anticancer Agents Med Chem; 2014; 14(9):1249-60. PubMed ID: 25060902
[TBL] [Abstract][Full Text] [Related]
31. Notoginsenoside Ft1 promotes angiogenesis via HIF-1α mediated VEGF secretion and the regulation of PI3K/AKT and Raf/MEK/ERK signaling pathways.
Shen K; Ji L; Gong C; Ma Y; Yang L; Fan Y; Hou M; Wang Z
Biochem Pharmacol; 2012 Sep; 84(6):784-92. PubMed ID: 22771629
[TBL] [Abstract][Full Text] [Related]
32. A hypoxia-dependent upregulation of hypoxia-inducible factor-1 by nuclear factor-κB promotes gastric tumour growth and angiogenesis.
Nam SY; Ko YS; Jung J; Yoon J; Kim YH; Choi YJ; Park JW; Chang MS; Kim WH; Lee BL
Br J Cancer; 2011 Jan; 104(1):166-74. PubMed ID: 21119667
[TBL] [Abstract][Full Text] [Related]
33. Secretogranin II impairs tumor growth and angiogenesis by promoting degradation of hypoxia-inducible factor-1α in colorectal cancer.
Fang C; Dai L; Wang C; Fan C; Yu Y; Yang L; Deng H; Zhou Z
Mol Oncol; 2021 Dec; 15(12):3513-3526. PubMed ID: 34160138
[TBL] [Abstract][Full Text] [Related]
34. Pomolic acid suppresses HIF1α/VEGF-mediated angiogenesis by targeting p38-MAPK and mTOR signaling cascades.
Park JH; Yoon J; Park B
Phytomedicine; 2016 Dec; 23(14):1716-1726. PubMed ID: 27912873
[TBL] [Abstract][Full Text] [Related]
35. Natural products as potent inhibitors of hypoxia-inducible factor-1α in cancer therapy.
Zhong JC; Li XB; Lyu WY; Ye WC; Zhang DM
Chin J Nat Med; 2020 Sep; 18(9):696-703. PubMed ID: 32928513
[TBL] [Abstract][Full Text] [Related]
36.
Canales J; Valenzuela M; Bravo J; Cerda-Opazo P; Jorquera C; Toledo H; Bravo D; Quest AF
Front Cell Infect Microbiol; 2017; 7():92. PubMed ID: 28401064
[No Abstract] [Full Text] [Related]
37. Upregulation of hypoxia inducible factor 1alpha mRNA is associated with elevated vascular endothelial growth factor expression and excessive angiogenesis and predicts a poor prognosis in gastric carcinoma.
Ma J; Zhang L; Ru GQ; Zhao ZS; Xu WJ
World J Gastroenterol; 2007 Mar; 13(11):1680-6. PubMed ID: 17461470
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia inducible factor-1α/vascular endothelial growth factor signaling activation correlates with response to radiotherapy and its inhibition reduces hypoxia-induced angiogenesis in lung cancer.
Zhu H; Zhang S
J Cell Biochem; 2018 Sep; 119(9):7707-7718. PubMed ID: 29904944
[TBL] [Abstract][Full Text] [Related]
39. Benzyl isothiocyanate suppresses pancreatic tumor angiogenesis and invasion by inhibiting HIF-α/VEGF/Rho-GTPases: pivotal role of STAT-3.
Boreddy SR; Sahu RP; Srivastava SK
PLoS One; 2011; 6(10):e25799. PubMed ID: 22016776
[TBL] [Abstract][Full Text] [Related]
40. Cinobufagin suppresses colorectal cancer angiogenesis by disrupting the endothelial mammalian target of rapamycin/hypoxia-inducible factor 1α axis.
Li X; Chen C; Dai Y; Huang C; Han Q; Jing L; Ma Y; Xu Y; Liu Y; Zhao L; Wang J; Sun X; Yao X
Cancer Sci; 2019 May; 110(5):1724-1734. PubMed ID: 30839155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
